Integer Holdings (ITGR) Stock Forecast & Price Target

Integer Holdings Corp has demonstrated robust financial performance, with a notable 15% revenue increase in its Cardio & Vascular segment and a steady growth trajectory anticipated for its overall portfolio, particularly in its core electrophysiology products. The company's gross margins are projected to remain stable, improving from 26.7% in 2024 to approximately 27.3% in 2025, signifying effective cost management and operational efficiency. Additionally, forecasted revenues of $1.87 billion for 2026, along with a rise in operating cash flow to between $230 million and $240 million, indicate a healthy financial outlook and reduction in leverage ratios, supporting Integer’s potential for above-market growth in the expanding cardiovascular device market.

Integer Holdings Corp has adjusted its estimates for 4Q25E, projecting revenues of $460.0 million, a decrease from previous expectations, alongside a lowered adjusted EPS forecast, indicating potential challenges in meeting prior growth expectations. The revised guidance for full-year 2025E reflects a $16 million reduction in revenue midpoints, exacerbated by a flat-to-lower outlook for 2026E stemming from decreased demand for key products. Furthermore, a slowdown in market adoption of critical offerings has led to a forecasted growth rate of only 0-4%, which represents a significant decline from historical performance metrics.